An evaluation of combinations of diaziquone, etoposide and mitoxantrone in the treatment of adults with relapsed or refractory acute myeloid leukemia: results of 8722, a randomized phase II study conducted by Cancer and Leukemia Group B (Q74371240)
Jump to navigation
Jump to search
scientific article published on 01 February 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An evaluation of combinations of diaziquone, etoposide and mitoxantrone in the treatment of adults with relapsed or refractory acute myeloid leukemia: results of 8722, a randomized phase II study conducted by Cancer and Leukemia Group B |
scientific article published on 01 February 1998 |
Statements
An evaluation of combinations of diaziquone, etoposide and mitoxantrone in the treatment of adults with relapsed or refractory acute myeloid leukemia: results of 8722, a randomized phase II study conducted by Cancer and Leukemia Group B (English)
E J Lee
S L George
P C Amrein
P A Paciucci
1 February 1998